Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

STRATA Skin Sciences (SSKN) EPS (Weighted Average and Diluted) (2016 - 2025)

STRATA Skin Sciences' EPS (Weighted Average and Diluted) history spans 12 years, with the latest figure at -$0.36 for Q3 2025.

  • For Q3 2025, EPS (Weighted Average and Diluted) rose 32.08% year-over-year to -$0.36; the TTM value through Sep 2025 reached -$2.64, down 6.45%, while the annual FY2024 figure was -$2.65, 14.52% up from the prior year.
  • EPS (Weighted Average and Diluted) for Q3 2025 was -$0.36 at STRATA Skin Sciences, up from -$0.62 in the prior quarter.
  • Across five years, EPS (Weighted Average and Diluted) topped out at $0.03 in Q2 2021 and bottomed at -$1.82 in Q4 2023.
  • The 5-year median for EPS (Weighted Average and Diluted) is -$0.08 (2023), against an average of -$0.35.
  • The largest annual shift saw EPS (Weighted Average and Diluted) surged 160.0% in 2021 before it crashed 52546.91% in 2023.
  • A 5-year view of EPS (Weighted Average and Diluted) shows it stood at -$0.03 in 2021, then soared by 88.48% to -$0.0 in 2022, then plummeted by 52546.91% to -$1.82 in 2023, then soared by 36.81% to -$1.15 in 2024, then skyrocketed by 68.7% to -$0.36 in 2025.
  • Per Business Quant, the three most recent readings for SSKN's EPS (Weighted Average and Diluted) are -$0.36 (Q3 2025), -$0.62 (Q2 2025), and -$0.51 (Q1 2025).